Rethinking Clinical Outcome Assessments: What Sentiment Analysis Reveals About Patient Feedback

Clinical Outcome Assessments (COAs) sit at the center of how sponsors evaluate treatment impact; capturing how patients feel and function throughout a clinical trial. As regulatory expectations for patient-focused drug development continue to evolve, the quality and interpretability of these measures have never been more important.

Currently, sponsors rely on traditional qualitative methods to assess COA performance. These methods remain a critical component of establishing content validity, helping to confirm whether items are relevant, clear, and meaningful to patients. However, analytical approaches, such as sentiment analysis, may provide new ways to deepen insights

A recent white paper from Fortrea’s Patient-Centered Endpoints (PaCE) team examines how sentiment analysis can inform the interpretation of patient feedback on COA items by classifying emotional tone in interview transcripts as positive, neutral, or negative. Item-level analyses of positive sentiment, word count, and item order revealed unique insights in addition to those obtained through traditional qualitative methods.

What the patient sentiment analysis data shows

Using transcripts from a cognitive debriefing study of a COVID-19 patient-reported outcome measure, sentiment analysis revealed several important patterns:

• Positive sentiment increased as interviews progressed, with later items receiving more favorable responses.
• Word count declined across item order, meaning patients provided less detailed feedback as interviews continued.
• A strong inverse relationship emerged: shorter responses were associated with more positive sentiment.
• Positive sentiment exceeded 50% across all items, suggesting patients generally found the measure clear, relevant, and easy to complete.

These findings point to a well-known but often under-recognized issue—satisficing. As patients move through an interview, cognitive effort can decline, leading to shorter, less critical responses that appear more positive on the surface.

What impact do these findings have on COAs?

For regulatory and clinical teams, these insights carry significant implications.

First, high levels of positive sentiment should not be interpreted in isolation. Without considering engagement levels and item order, there is a risk of overestimating the strength of patient endorsement.

Second, sentiment analysis can help pinpoint which items may require refinement. Lower positive or higher negative sentiment can signal issues with clarity, relevance, or interpretability—supporting more targeted improvements.

Third, this approach provides a new, additional, way to assess interview quality and design. Detecting patterns consistent with satisficing allows teams to explore mitigation strategies, such as randomizing item order or introducing more active engagement checks throughout interviews.

What can sponsors do to strengthen cognitive debriefings?

For sponsors preparing for regulatory interactions or optimizing COA strategies, the implications are clear:

• Consider applying sentiment analysis alongside traditional qualitative methods to inform item-level decisions during development
• Reassess how cognitive debriefing data is interpreted—particularly where results appear uniformly positive
• Evaluate study design to reduce bias introduced by fatigue or declining engagement

This is not about replacing established methods—it is about strengthening them with additional layers of evidence that better reflect the patient voice.

Access the full analysis white paper

Sentiment analysis represents a practical, scalable way to extract deeper value from existing data and challenge assumptions in COA evaluation.

To explore the methodology, detailed findings, and implications for regulatory strategy, download the full white paper.

Read the full white paper and connect with Fortrea’s Consulting and PaCE team to discuss how these insights can inform your next program.